HAEMOKINESIS
Haemokinesis is a global leader in immunohaematology diagnostics, dedicated to developing innovative solutions in blood grouping and emergency medicine. Founded in 2011 and headquartered in Melbourne, Australia, with a Swiss facility, the company aims to provide fast, safe, and reliable blood testing technology to improve patient outcomes worldwide. Their mission is to remove barriers to healthcare access through advanced blood diagnostic and point-of-care solutions, striving to make every second count in saving lives.
Industries
Nr. of Employees
small (1-50)
HAEMOKINESIS
16 Technology Circuit, Hallam VIC 3803 Australia
Patents
Products
Rapid one-minute forward/reverse blood grouping test
A rapid serological test format enabling forward and reverse blood group determination in approximately one minute, intended for emergency and trauma settings.
Semi-automated 10-minute antibody screen/ID/crossmatch suite
Semi-automated gel-based consumables and workflows that perform antibody screening, antibody identification and crossmatching in roughly ten minutes.
Automated single-well immunohaematology analyser
Automated analyser platform that processes individual wells sequentially to support gel-card serology workflows for laboratories requiring automation.
High-throughput gel analyser platform
High-capacity analyser designed for large laboratories that require increased throughput, capacity and STAT/sample management for gel-based tests.
Whole-blood quality control materials
Whole-blood QC products formulated to be comparable to real patient samples for use in routine quality control and validation of serological workflows.
Rapid one-minute forward/reverse blood grouping test
A rapid serological test format enabling forward and reverse blood group determination in approximately one minute, intended for emergency and trauma settings.
Semi-automated 10-minute antibody screen/ID/crossmatch suite
Semi-automated gel-based consumables and workflows that perform antibody screening, antibody identification and crossmatching in roughly ten minutes.
Automated single-well immunohaematology analyser
Automated analyser platform that processes individual wells sequentially to support gel-card serology workflows for laboratories requiring automation.
High-throughput gel analyser platform
High-capacity analyser designed for large laboratories that require increased throughput, capacity and STAT/sample management for gel-based tests.
Whole-blood quality control materials
Whole-blood QC products formulated to be comparable to real patient samples for use in routine quality control and validation of serological workflows.
Services
Onboarding, installation and post-sale technical support for diagnostic analysers and consumables.
Training programs and production/validation support for laboratory staff and distributors, delivered via company training facilities and partner channels.
Management of distributor channels, regional warehouses and logistics to deliver instruments and consumables internationally.
Onboarding, installation and post-sale technical support for diagnostic analysers and consumables.
Training programs and production/validation support for laboratory staff and distributors, delivered via company training facilities and partner channels.
Management of distributor channels, regional warehouses and logistics to deliver instruments and consumables internationally.
Expertise Areas
- Immunohaematology diagnostics
- Point-of-care and emergency blood grouping
- Laboratory automation for transfusion testing
- Diagnostic reagent and consumables manufacturing
Key Technologies
- Gel-card immunohaematology assays
- Single well-by-well automated processing
- High-throughput analyser automation
- Laser-based incubation
News & Updates
Celebrating 10 years since establishment in Melbourne, Australia.
Participation in the Blood 2022 event from September 11-14, 2022.
The company received ISO 13485 certification supporting medical device quality management systems.
Received ARC linkage grant to develop in-vitro diagnostics.
Received CE certification for these blood typing products.
Achieved ISO 13485 medical device quality management system certification.
Celebrating 10 years since establishment in Melbourne, Australia.
Participation in the Blood 2022 event from September 11-14, 2022.
The company received ISO 13485 certification supporting medical device quality management systems.
Received ARC linkage grant to develop in-vitro diagnostics.
Received CE certification for these blood typing products.
Achieved ISO 13485 medical device quality management system certification.